首页> 外文期刊>Current topics in medicinal chemistry >Learning from Multiple Classifier Systems: Perspectives for Improving Decision Making of QSAR Models in Medicinal Chemistry
【24h】

Learning from Multiple Classifier Systems: Perspectives for Improving Decision Making of QSAR Models in Medicinal Chemistry

机译:从多种分类器系统中学习:改进药用化学中QSAR模型决策的透视图

获取原文
获取原文并翻译 | 示例
           

摘要

Quantitative Structure - Activity Relationship (QSAR) modeling has been widely used in medicinal chemistry and computational toxicology for many years. Today, as the amount of chemicals is increasing dramatically, QSAR methods have become pivotal for the purpose of handling the data, identifying a decision, and gathering useful information from data processing. The advances in this field have paved a way for numerous alternative approaches that require deep mathematics in order to enhance the learning capability of QSAR models. One of these directions is the use of Multiple Classifier Systems (MCSs) that potentially provide a means to exploit the advantages of manifold learning through decomposition frameworks, while improving generalization and predictive performance. In this paper, we presented MCS as a next generation of QSAR modeling techniques and discuss the chance to mining the vast number of models already published in the literature. We systematically revisited the theoretical frameworks of MCS as well as current advances in MCS application for QSAR practice. Furthermore, we illustrated our idea by describing ensemble approaches on modeling histone deacetylase (HDACs) inhibitors. We expect that our analysis would contribute to a better understanding about MCS application and its future perspectives for improving the decision making of QSAR models.
机译:定量结构 - 活动关系(QSAR)建模已广泛用于药物化学和计算毒理学多年。如今,随着化学品的量急剧增加,QSAR方法已经成为处理数据,识别决定和从数据处理收集有用信息的枢转。该领域的进展为需要深入数学的许多替代方法铺平了一种方法,以提高QSAR模型的学习能力。这些方向之一是使用多种分类器系统(MCS),其可能提供通过分解框架利用歧管学习的优点的方法,同时提高泛化和预测性能。在本文中,我们将MCS作为下一代QSAR建模技术展示,并讨论了挖掘在文献中已发表的大量模型的机会。我们系统地重新讨论了MCS的理论框架以及MCS应用程序的当前进步,以便QSAR实践。此外,我们通过描述了组蛋白脱乙酰化酶(HDACS)抑制剂的集合方法来说明了我们的想法。我们预计我们的分析将有助于更好地了解MCS应用程序及其未来对提高QSAR模型决策的观点的观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号